Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sue Reichwein"'
Autor:
Lorelei Derwent, Chadwick W. Christine, Alicia H. Augustine, Zoltan Mari, Richard B. Dewey, Jessie Roth, Maureen A. Leehey, Kelvin L. Chou, Nabila Dahodwala, Sheng Luo, Sotirios A. Parashos, Katherine B. Hawthorne, Caroline M. Tanner, Franca Cambi, Helen Petrovitch, Karl Kieburtz, Mark F. Lew, Suja S. Rajan, Jay S. Schneider, Jordan J. Elm, Carlos Singer, Michelle Cines, James T. Boyd, Ivan Bodis-Wollner, G. Webster Ross, Karen Williams, Chizoba C. Umeh, Michael J. Aminoff, David J. Houghton, Grace S. Liang, Cornelia Kamp, Lewis Sudarsky, Barbara C. Tilley, Robert A. Hauser, Debra Babcock, John C. Morgan, Erika U. Augustine, Adriana Pérez, Kathleen M. Shannon, David Simon, Tanya Simuni, Sue Reichwein, Anne-Marie Wills
Publikováno v:
JAMA. 313:584
Importance There are no treatments available to slow or prevent the progression of Parkinson disease, despite its global prevalence and significant health care burden. The National Institute of Neurological Disorders and Stroke Exploratory Trials in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef36ee0e298e8b880bfb48367249ed54
https://doi.org/10.1001/jama.2015.120
https://doi.org/10.1001/jama.2015.120
Autor:
M Gillespie, M M Trieschmann, Anthony Crawley, Bernard Ravina, John T. Farrar, Tanya Simuni, Andrew Siderowf, Mary E. Putt, Hubert H. Fernandez, Sue Reichwein
Objective: To study the safety and efficacy of a cholinesterase inhibitor, donepezil hydrochloride, for the treatment of dementia in Parkinson's disease (PD). Methods: This was a randomised double blind, placebo controlled, crossover study in 22 subj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::831620807b7c57384378d06c2f6330d4
https://europepmc.org/articles/PMC1739697/
https://europepmc.org/articles/PMC1739697/
